HSBC Holdings
PRCT icon

HSBC Holdings’s Procept Biorobotics PRCT Stock Holding History

HSBC Holdings’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63M Sell
160,586
-178,300
-53% -$4.46M ﹤0.01% 1338
2026
Q1 		$8.5M Buy
+338,886
New +$9.55M ﹤0.01% 977
2025
Q4 		– Sell
-242,611
Closed -$8.66M – 3112
2025
Q3 		$8.66M Buy
242,611
+29,445
+14% +$1.34M ﹤0.01% 981
2025
Q2 		$12.3M Buy
213,166
+50,122
+31% +$2.83M 0.01% 840
2025
Q1 		$9.5M Buy
163,044
+20,234
+14% +$1.38M 0.01% 909
2024
Q4 		$11.5M Sell
142,810
-11,021
-7% -$942K 0.01% 894
2024
Q3 		$12.3M Buy
+153,831
New +$10.9M 0.01% 861
2024
Q2 		– Sell
-133,633
Closed -$6.59M – 3124
2024
Q1 		$6.59M Buy
133,633
+26,763
+25% +$1.27M ﹤0.01% 1005
2023
Q4 		$4.48M Buy
106,870
+25,440
+31% +$866K ﹤0.01% 1189
2023
Q3 		$2.67M Buy
81,430
+8,064
+11% +$275K ﹤0.01% 1330
2023
Q2 		$2.59M Buy
+73,366
New +$2.43M ﹤0.01% 1330

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HSBC Holdings's PRCT Position: Q2 2026 in Review

HSBC Holdings reduced its Procept Biorobotics (PRCT) stake by 53% in Q2 2026, selling an estimated $4.46M and leaving 160,586 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

HSBC Holdings first reported a position in PRCT in Q2 2023 and has held it in 11 quarters since. The position peaked at $12.3M in Q3 2024. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • HSBC Holdings held 160,586 shares of Procept Biorobotics worth $3.63M as of Q2 2026.
  • HSBC Holdings sold 178,300 Procept Biorobotics shares in Q2 2026, an estimated $4.46M.
  • Procept Biorobotics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1338 holding.
  • HSBC Holdings first reported a position in Procept Biorobotics in Q2 2023 and has held it in 11 quarters since.
  • HSBC Holdings's Procept Biorobotics position peaked at $12.3M in Q3 2024.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.